Results 181 to 190 of about 722,267 (211)

The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

Journal of Clinical Oncology, 2003
Richard J Gralla, Fausto Roila, Alexandra D Carides   +2 more
exaly  

A Factorial Trial of Six Interventions for the Prevention of Postoperative Nausea and Vomiting

New England Journal of Medicine, 2004
Markus Kredel, Daniel I Sessler
exaly  

Erotic vomiting

Archives of Sexual Behavior, 1982
openaire   +2 more sources

Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting

New England Journal of Medicine, 2016
Matti Aapro
exaly  

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting

New England Journal of Medicine, 2016
Kathryn J Ruddy, Charles L Loprinzi
exaly  

Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer After Moderately Emetogenic Chemotherapy

Journal of Clinical Oncology, 2005
Richard J Gralla, Anthony Rodgers
exaly  

Nausea, Vomiting, and Retching: Complex Problems in Palliative Care

Ca-A Cancer Journal for Clinicians, 2001
exaly  

Consensus Guidelines for the Management of Postoperative Nausea and Vomiting

Anesthesia and Analgesia, 2014
Tong J Gan, Ashraf S Habib, Anthony L Kovac   +2 more
exaly  

Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial

Lancet Oncology, The, 2015
Lee S Schwartzberg, Rudolph M Navari
exaly  

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

Ca-A Cancer Journal for Clinicians, 2013
exaly